The objective of this review is to summarize the findings of published research that
investigated the relationship between diabetes mellitus and gastric cancer (GCa) and the …

Increasing evidence suggests that metformin use is associated with a decreased risk of
cancer. The traditional therapies for gastric cancer (GC) are gastrectomy and …

Objectives The objective of this study was to evaluate the association between metformin
therapy and the incidence of gastric cancer (GC) in patients with type 2 diabetes mellitus …

This review summarizes the correlation between diabetes mellitus (DM) and gastric cancer
(GC) from the perspectives of epidemiology, drug use, and potential mechanisms. The …

Background Metformin, a drug widely used in the treatment of diabetes, has proven
preventive and survival benefits for various malignancies. However, the effect of metformin …

Diabetes mellitus is associated with a high risk of developing gastric cancer (GC). Metformin,
which is conventionally used to treat type 2 diabetes, induces AMP-activated protein kinase …

This retrospective cohort study investigated whether metformin may reduce gastric cancer
risk by using the reimbursement databases of the Taiwan's National Health Insurance …

Background Gastric cancer (GC) is one of the most common worldwide cancers and causes
of death. Various studies have investigated the effect of metformin on overall survival (OS) …

We assessed gastric cancer risk in type 2 diabetes mellitus patients. Gastric cancer patients
with diabetes between 2001–2012 were identified. Four groups were analysed: combination …

Patients with diabetes mellitus (DM) are at increased risk of developing several cancers;
however, there is a lack of consensus on the relationship between gastric cancer (GC) and …